Impact of acid inhibition on esophageal mucosal injury induced by low-dose aspirin (Q42723357)

5 November 2017

Impact of acid inhibition on esophageal mucosal injury induced by low-dose aspirin (English)

1 reference

5 November 2017

1 reference

Mitsushige Sugimoto

1

1 reference

5 November 2017

Masafumi Nishino

2

1 reference

5 November 2017

Chise Kodaira

3

1 reference

5 November 2017

Mihoko Yamade

4

1 reference

5 November 2017

Takahiro Uotani

5

1 reference

5 November 2017

Mutsuhiro Ikuma

6

1 reference

5 November 2017

Takahisa Furuta

7

1 reference

5 November 2017

24 November 2011

1 reference

5 November 2017

1 reference

5 November 2017

85

1 reference

5 November 2017

1

1 reference

5 November 2017

9-17

1 reference

5 November 2017

1 reference

Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s

21 January 2018

1 reference

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

21 January 2018

1 reference

Prophylactic aspirin and risk of peptic ulcer bleeding

21 January 2018

1 reference

Relationship between low-dose aspirin-induced gastric mucosal injury and intragastric pH in healthy volunteers

21 January 2018

1 reference

Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.

21 January 2018

1 reference

Epidemiological study of gastro-oesophageal reflux disease: reflux in spouse as a risk factor.

21 January 2018

1 reference

It is possible to classify non-erosive reflux disease (NERD) patients into endoscopically normal groups and minimal change groups by subjective symptoms and responsiveness to rabeprazole -- a report from a study with Japanese patients

21 January 2018

1 reference

Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan

21 January 2018

1 reference

Esophageal mucosal injury with low-dose aspirin and its prevention by rabeprazole

21 January 2018

1 reference

Risk factors of oesophagitis in arthritic patients

21 January 2018

1 reference

Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population

21 January 2018

1 reference

Natural history of gastro-oesophageal reflux disease diagnosed in general practice.

21 January 2018

1 reference

Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study.

21 January 2018

1 reference

Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19.

21 January 2018

1 reference

Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer.

21 January 2018

1 reference

Review article: oesophageal mucosal resistance

21 January 2018

1 reference

Nonsteroidal antiinflammatory drugs and esophageal injury

21 January 2018

1 reference

Role of bile acids, prostaglandins and COX inhibitors in chronic esophagitis in a mouse model

21 January 2018

1 reference

The effects of esomeprazole combined with aspirin or rofecoxib on prostaglandin E2 production in patients with Barrett's oesophagus

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000329295

1 reference

5 November 2017

1 reference